Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

InnovaQor, Inc. VMCS OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
10/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

InnovaQor, Inc. (VMCS) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $0.01. It has a SharesGrow Score of 9/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $343,440, +5.8%/yr average growth. Net income is $2M (loss), growing at -11.3%/yr. Net profit margin is -596.5% (negative). Gross margin is -9.4% (-52.7 pp trend).

Balance sheet: total debt is $2M against $137,250 equity (Debt-to-Equity (D/E) ratio 11.9, leveraged). Current ratio is 0.01 (tight liquidity). Debt-to-assets is 3921.2%. Total assets: $41,641.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 40/100 (Partial), Past 0/100 (Fail), Health 0/100 (Fail), Moat 0/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

VMCS SharesGrow Score Overview

25/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 40/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 0/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 0/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — VMCS

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
40/100
VMCS: +5.8%/yr revenue is, -11.3%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
—
HEALTH N/A
N/A
No analyst coverage available for this stock.
—
MOAT N/A
N/A
No analyst coverage available for this stock.
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
VMCS: Net profit margin is -596.5%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0022-0.0158
Volume791.39K
Avg Volume (30D)106.93K
Beta (1Y)0.00
Share Statistics
Employees9
CEOGerard Dab
Financial Highlights & Ratios
Revenue (TTM)$343.44K
Gross Profit$-32.28K
EBITDA$-1.4M
Net Income$-2.05M
Operating Income$-1.83M
Total Cash$5.42K
Total Debt$1.63M
Net Debt$1.63M
Total Assets$41.64K
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD

Price Chart

Track all markets on TradingView
VMCS
InnovaQor, Inc. ↗  ·  Other OTC
Healthcare • Medical - Healthcare Information Services
0.00 52WK RANGE 0.02

People Also View

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message